• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Veru Moves Forward with Late-Stage COVID Study Despite FDA Roadblock

cafead

Administrator
Staff member
  • cafead   Mar 15, 2023 at 10:32: AM
via Weeks after the FDA rejected Veru’s Emergency Use Authorization (EUA) bid for sabizabulin in COVID-19, the company announced plans to continue with late-stage development of the drug.

article source
 

<